Sansure Biotech Inc. (688289.SS)
CNY 22.2
(0.0%)
CNY 22.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1 Billion | 6.45 Billion | 4.51 Billion | 4.76 Billion | 365.38 Million | 303.44 Million |
| Cost of Revenue | 381.81 Million | 2.65 Billion | 1.27 Billion | 969.95 Million | 127.3 Million | 126.04 Million |
| Gross Profit | 620.65 Million | 3.79 Billion | 3.23 Billion | 3.79 Billion | 238.07 Million | 177.4 Million |
| Operating Expenses | 638.67 Million | 1.26 Billion | 666.89 Million | 680.87 Million | 188.66 Million | 163.74 Million |
| Selling, General and Administrative Expenses | 482.21 Million | 834.85 Million | 434.89 Million | 558.53 Million | 134.97 Million | 109.16 Million |
| Research and Development Expenses | 167.06 Million | 331.83 Million | 187.5 Million | 82.77 Million | 38.95 Million | 35.68 Million |
| Other Expenses | 10.6 Million | 95.45 Million | 44.49 Million | 39.57 Million | 14.73 Million | -1.01 Million |
| Cost and Expenses | 579.65 Million | 3.91 Billion | 1.94 Billion | 1.65 Billion | 315.97 Million | 289.78 Million |
| Operating Income | 427.46 Million | 2.33 Billion | 2.62 Billion | 3.08 Billion | 47.51 Million | 11.7 Million |
| Interest Expense | 5.53 Million | 2.09 Million | 829.41 Thousand | 508.16 Thousand | 519.63 Thousand | 3.16 Million |
| Income Tax Expense | 62.31 Million | 379.21 Million | 373.68 Million | 453.56 Million | 5.98 Million | 3.92 Million |
| Earnings before Tax | 410.47 Million | 2.31 Billion | 2.61 Billion | 3.07 Billion | 45.46 Million | 10.68 Million |
| Net Income | 363.72 Million | 1.93 Billion | 2.24 Billion | 2.61 Billion | 39.47 Million | 6.76 Million |
| Earnings Per Share Basic | 0.64 | 3.35 | 3.79 | 4.42 | 0.07 | 0.02 |
| Earnings Per Share Diluted | 0.64 | 3.35 | 3.79 | 4.42 | 0.07 | 0.02 |
| Weighted Average Shares Outstanding | 572.17 Million | 578.69 Million | 591.65 Million | 592 Million | 592 Million | 358.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 572.17 Million | 578.69 Million | 591.65 Million | 592 Million | 592 Million | 358.89 Million |
| Gross Margin | 0.62 | 0.59 | 0.72 | 0.80 | 0.65 | 0.58 |
| EBIT Margin | 0.57 | 0.41 | 0.58 | 0.65 | 0.19 | 0.13 |
| Profit Margin | 0.36 | 0.30 | 0.50 | 0.55 | 0.11 | 0.02 |
| EBITDA | 574.93 Million | 2.43 Billion | 2.67 Billion | 3.09 Billion | 68.62 Million | 32.46 Million |
| Earnings Before Tax Margin | 0.43 | 0.36 | 0.58 | 0.65 | 0.13 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 315.62 Million | 323.54 Million | 388.58 Million | 1 Billion | 371.65 Million | 204.84 Million |
| Cost of Revenue | 69.31 Million | 119 Million | 73.9 Million | 381.81 Million | 116.61 Million | 55.53 Million |
| Gross Profit | 246.3 Million | 204.54 Million | 314.68 Million | 620.65 Million | 255.04 Million | 149.31 Million |
| Operating Expenses | 236.46 Million | 185 Million | 230.98 Million | 638.67 Million | 233.1 Million | 168.45 Million |
| Selling, General and Administrative Expenses | 354.39 Million | 137.8 Million | 179.97 Million | - | 190.73 Million | 172.44 Million |
| Research and Development Expenses | 72.29 Million | 52.65 Million | 55.4 Million | - | 48.98 Million | 46.97 Million |
| Other Expenses | -190.23 Million | 5.45 Million | 4.39 Million | 10.6 Million | 6.61 Million | -10.87 Million |
| Cost and Expenses | 305.78 Million | 304 Million | 304.88 Million | 1.02 Billion | 349.71 Million | 223.99 Million |
| Operating Income | 34.23 Million | 19.53 Million | 83.7 Million | -18.02 Million | 21.94 Million | 254.95 Million |
| Interest Expense | 5.47 Million | 5.94 Million | 5.38 Million | 2.4 Million | 1.49 Million | 700.99 Thousand |
| Income Tax Expense | 4.48 Million | 13.72 Million | 18.92 Million | 62.31 Million | 8.67 Million | 36.51 Million |
| Earnings before Tax | 31.9 Million | 79.39 Million | 109.24 Million | 432.63 Million | 56.84 Million | 244.07 Million |
| Net Income | 38.72 Million | 75.68 Million | 81.02 Million | 363.72 Million | 63.99 Million | 208.04 Million |
| Earnings Per Share Basic | 0.07 | 0.13 | 0.14 | - | 0.11 | 0.36 |
| Earnings Per Share Diluted | 0.07 | 0.13 | 0.14 | - | 0.11 | 0.36 |
| Weighted Average Shares Outstanding | 573.72 Million | 573.52 Million | 573.52 Million | 572.17 Million | 572.17 Million | 572.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 573.72 Million | 573.52 Million | 573.52 Million | 572.17 Million | 572.17 Million | 572.2 Million |
| Gross Margin | 0.78 | 0.63 | 0.81 | 0.62 | 0.69 | 0.73 |
| EBIT Margin | 0.12 | 0.19 | 0.23 | - | 0.15 | 1.14 |
| Profit Margin | 0.12 | 0.23 | 0.21 | 0.36 | 0.17 | 1.02 |
| EBITDA | 37.38 Million | 60.51 Million | 88.69 Million | - | 57.54 Million | 233.68 Million |
| Earnings Before Tax Margin | 0.11 | 0.06 | 0.22 | -0.02 | 0.06 | 1.24 |
7608
1258
RYSMF
GULFPETRO
ICICIGI
034590